HRSA Publishing “Interpretative” 340B Orphan Drug Rule

by Admin | July 14, 2014 2:23 pm

July 14, 2014—The Health Resources and Services Administration is publishing a new 340B program rule in the Federal Register requiring drug manufacturers to give rural and free-standing cancer hospitals discounts on orphan drugs when used for non-orphan indications, Office of Pharmacy Affairs Director Cmdr. Krista Pedley said today. 

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1].    Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Endnotes:
  1. Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
  2. Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2014/07/hrsa-publishing-interpretative-340b-orphan-drug-rule/

Copyright ©2026 340binformed.org unless otherwise noted.